About Health Catalyst Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.healthcatalyst.com/
Frequently Asked Questions
What is the 52-week range for HCAT?
The 52-week high is $3.615 and the 52-week low is $0.955.
What is the P/E ratio for HCAT?
The P/E ratio data is currently unavailable.
What is the dividend yield for HCAT?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -129.70%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -90.61%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 0.69.
Analyst Recommendation Trends
Wall Street analyst consensus for HCAT over the last few months:
Latest HCAT News
Health Catalyst (HCAT): Buy, Sell, or Hold Post Q2 Earnings?
What a time it’s been for Health Catalyst. In the past six months alone, the company’s stock price has increased by a massive 48.7%, reaching $1.76 per share. This performance may have investors wondering how to approach the situation.
3 Software Stocks We’re Skeptical Of
Software is eating the world, and virtually no business is left untouched by it. The undeniable tailwinds fueling the industry have also led to strong returns for SaaS stocks lately as they’ve gained 47.2% over the past six months, outpacing the S&P 500’s 21.4% rise.
3 Unprofitable Stocks That Fall Short
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
Health Catalyst (HCAT) Stock Fair Value Falls As Analysts Cut Targets On Growth Risks
Health Catalyst is back in focus after analysts revised fair value from about US$2.10 to roughly US$1.83 per share, which points to a more cautious stance on the stock. Recent research has shifted from earlier optimism with price targets in the US$2 to US$3 range to current levels closer to US$1.80, as analysts weigh execution risks around churn, divestitures and the durability of growth in its health technology offerings. In this article, you will see how these changing targets fit into the...
3 Small-Cap Stocks We Steer Clear Of
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
Population Health Management Market by Component, Functionality, End User, Organization Size - Global Forecast to 2031
The population health management market is projected to grow from USD 46.93 billion in 2026 to USD 98.41 billion by 2031, registering a 16.0% CAGR. Growth is driven by value-based care, chronic disease prevalence, cost reduction, and demand for improved patient outcomes. Software led the market in 2025, while cloud-based PHM solutions are set to grow fastest, supported by AI, predictive analytics, remote patient monitoring, and interoperable data. Asia Pacific is expected to record the highest C
Health Catalyst Reports Q2 2026 Results: Full Earnings Call Transcript
Health Catalyst (NASDAQ:HCAT) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and
Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SALT LAKE CITY, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that on September 14, 2026, the Compensation Committee of the Company’s Board of Directors granted 2,747,385 restricted stock units (the “RSUs”) to Simeon Kohl under the Health Catalyst, Inc. 2026 Employment Inducement Incentive Plan (the “Inducement Plan”) i
Health Catalyst Strengthens Its Board with the Appointment of Tami Reller
Health Catalyst, Inc. ("Health Catalyst", NASDAQ: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Tami Reller has been appointed to its board of directors (Board), effective October 1, 2026. Reller will serve as audit chair and as a member of its compensation committee, also effective October 1, 2026.
3 Value Stocks That Concern Us
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
Health Catalyst appoints new CEO
The data analytics company has cycled through three CEOs in eight months. Health Catalyst is betting its newest chief can navigate an AI pivot and revenue headwinds.
Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President
Kohl brings public-company leadership and a record of successful transformation; Ben Albert to continue as Chief Business OfficerSALT LAKE CITY, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Simeon Kohl has been appointed Chief Executive Officer (CEO) and President and a member of the Company’s Board of Directors,
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-14 | Kohl Simeon | +59,000 | $1.7871 | $105,439 |
| 2026-09-14 | Kohl Simeon | +2,747,385 | - | - |
| 2026-09-10 | Albert Benjamin | -35,244 | $1.6747 | $59,023 |
| 2026-09-01 | Albert Benjamin | -321 | $1.7036 | $547 |
| 2026-09-01 | Landry Benjamin | -13,167 | $1.7036 | $22,431 |
| 2026-09-01 | Alger Jason | -17,973 | $1.7036 | $30,619 |
| 2026-09-01 | Larson-Green Julie | +9,766 | - | - |
| 2026-07-16 | Hoggard Green Jill | +80,691 | - | - |
| 2026-07-16 | Larson-Green Julie | +80,691 | - | - |
| 2026-07-16 | Spencer Justin | +80,691 | - | - |
| 2026-07-16 | Nelson Steven H | +80,691 | - | - |
| 2026-06-10 | Albert Benjamin | -34,485 | $1.6918 | $58,342 |
| 2026-06-01 | Albert Benjamin | -336 | $1.3702 | $460 |
| 2026-06-01 | Landry Benjamin | -13,779 | $1.3702 | $18,880 |
| 2026-06-01 | Alger Jason | -18,804 | $1.3702 | $25,765 |
| 2026-06-01 | Larson-Green Julie | +12,710 | - | - |
| 2026-06-01 | Llewelyn Linda | -8,519 | $1.3702 | $11,673 |
| 2026-05-01 | Nelson Steven H | +154,808 | - | - |
| 2026-05-01 | Albert Benjamin | -310 | $1.345 | $417 |
| 2026-04-29 | Albert Benjamin | +1,124 | - | - |
| 2026-03-10 | Albert Benjamin | -70,455 | $1.8481 | $130,208 |
| 2026-03-02 | Albert Benjamin | -4,966 | $1.6599 | $8,243 |
| 2026-03-02 | Landry Benjamin | -20,838 | $1.6599 | $34,589 |
| 2026-03-02 | Alger Jason | -26,970 | $1.6599 | $44,768 |
| 2026-03-02 | Llewelyn Linda | -13,836 | $1.6599 | $22,966 |
| 2026-03-01 | Larson-Green Julie | +8,361 | - | - |
| 2026-02-26 | Albert Benjamin | -13,304 | $1.7478 | $23,253 |
| 2026-02-26 | Alger Jason | -7,522 | $1.7478 | $13,147 |
| 2026-02-26 | Landry Benjamin | -6,317 | $1.7478 | $11,041 |
| 2026-02-26 | Llewelyn Linda | -4,471 | $1.7478 | $7,814 |
| 2026-02-25 | Albert Benjamin | +38,833 | - | - |
| 2026-02-25 | Albert Benjamin | +930,000 | - | - |
| 2026-02-25 | Alger Jason | +22,222 | - | - |
| 2026-02-25 | Alger Jason | +507,500 | - | - |
| 2026-02-25 | Landry Benjamin | +16,473 | - | - |
| 2026-02-25 | Landry Benjamin | +289,000 | - | - |
| 2026-02-25 | Llewelyn Linda | +13,195 | - | - |
| 2026-02-25 | Llewelyn Linda | +191,500 | - | - |
| 2026-02-17 | Gallagher Duncan | +7,562 | - | - |
| 2025-12-05 | Landry Benjamin | -27,425 | $2.6373 | $72,328 |
| 2025-12-04 | Larson-Green Julie | -47,997 | $2.6741 | $128,349 |
| 2025-12-01 | Landry Benjamin | -14,387 | $2.9002 | $41,725 |
| 2025-12-01 | Freeman Kevin Lee | -16,401 | $2.9002 | $47,566 |
| 2025-12-01 | Alger Jason | -20,619 | $2.9002 | $59,799 |
| 2025-12-01 | Larson-Green Julie | +5,731 | - | - |
| 2025-12-01 | Burton Daniel D. | -55,715 | $2.9002 | $161,585 |
| 2025-12-01 | Gallagher Duncan | +6,209 | - | - |
| 2025-12-01 | Llewelyn Linda | -9,762 | $2.9002 | $28,312 |